FDA approves 1st-ever drug to treat disabling skin condition prurigo nodularis (WTOP.com)

October 3, 2022
FDA approves 1st-ever drug to treat disabling skin condition prurigo nodularis

The first and only treatment for the disabling skin condition prurigo nodularis has been approved by the Food and Drug Administration in a development a D.C. dermatologist calls “huge.”

Prurigo nodularis is a persistent condition that causes itching so intense that it disrupts sleep. It can prompt so much scratching that skin starts to bleed; it results in thick skin lesions called nodules, which can cover almost the entire body.

“The impact of prurigo nodularis on quality of life is one of the highest among inflammatory skin diseases and can negatively affect mental health, activities of daily living and social interactions,” said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences.

Read the full article on WTOP.com

Latest News

February 2, 2023
Spring may be just around the corner, but winter is still here with more cold days in the forecast. Those conditions that your body experiences when the weather is frigid, can spell bad news for your skin.
January 29, 2023
Treatment for hyperhidrosis, or excessive sweating, depends on where on your body you're sweating. Also, you may need to try different approaches, or a combination, to find relief.
January 27, 2023
Dermatologists explain what's worrisome and what's NBD.